DPP-IV drugs are supposed to help patients control their diabetes with fewer side effects than older medicines.

FORBES: For Merck, A New Worry Amid Success

Consider, for example, sitagliptin, a DPP-IV inhibitor developed for the treatment of diabetes.

FORBES: Why Is Medicine's Killer App an E-textbook?